» Authors » Robert B McCully

Robert B McCully

Explore the profile of Robert B McCully including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 75
Citations 1013
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Fazzini L, Hubers S, Cao J, Scott C, McCully R, Castrichini M, et al.
J Am Soc Echocardiogr . 2024 Nov; PMID: 39613116
Background: During exercise stress echocardiography (ESE), there are patients with normal left ventricular ejection fraction (LVEF) who paradoxically develop reduced LVEF during exercise despite absence of coronary artery disease (CAD)...
2.
Stanko K, Thomas A, Cullen M, McCully R, Schroeder D, Kane G, et al.
J Am Soc Echocardiogr . 2024 Mar; 37(6):641-643. PMID: 38458360
No abstract available.
3.
Bailey M, Durst L, Cajigas H, Kane G, Krowka M, Kushwaha S, et al.
Pulm Circ . 2024 Feb; 14(1):e12343. PMID: 38344072
Chronic lung disease (CLD) is the second leading cause of pulmonary hypertension (PH) and is associated with significant morbidity and mortality. Although PH associated with CLD (PH-CLD) leads to impaired...
4.
Awasthi S, Sachdeva N, Gupta Y, Anto A, Asfahan S, Abbou R, et al.
EClinicalMedicine . 2023 Dec; 65:102259. PMID: 38106563
Background: Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death worldwide, driven primarily by coronary artery disease (CAD). ASCVD risk estimators such as the pooled cohort equations (PCE) facilitate...
5.
Luong C, Anand V, Padang R, Oh J, Arruda-Olson A, Bird J, et al.
J Am Soc Echocardiogr . 2023 Nov; 37(4):382-393.e1. PMID: 38000684
Background: Exercise echocardiography can assess for cardiovascular causes of dyspnea other than coronary artery disease. However, the prevalence and prognostic significance of elevated left ventricular (LV) filling pressures with exercise...
6.
Ali M, Johnson M, Irwin T, Henry S, Sugeng L, Kansal S, et al.
J Am Soc Echocardiogr . 2023 Oct; 37(3):276-284.e3. PMID: 37879379
Objectives: Prior data indicate a very rare risk of serious adverse drug reaction (ADR) to ultrasound enhancement agents (UEAs). We sought to evaluate the frequency of ADR to UEA administration...
7.
Salama A, Padang R, Thaden J, Kane C, Elwazir M, Anand V, et al.
J Am Soc Echocardiogr . 2023 Jan; 36(6):667-670. PMID: 36669594
No abstract available.
8.
Lyle M, Bhatia S, Fenstad E, Schroeder D, McCully R, Lacy M, et al.
Adv Hematol . 2022 Nov; 2022:8918959. PMID: 36438612
Objective: To determine the prevalence of monoclonal gammopathy of undetermined significance (MGUS) in patients with PH as well as precapillary PH. Methods: Olmsted County residents with PH, diagnosed between 1/1/1995...
9.
DuBrock H, Reddy Y, Durst L, Schroeder D, Park G, Cajigas H, et al.
Pulm Circ . 2022 Oct; 12(4):e12143. PMID: 36262468
Pulmonary arterial hypertension (PAH) is a progressive pulmonary vascular disease that negatively impacts health-related quality of life (HRQOL). The PAH-symptoms and impact (PAH-SYMPACT) questionnaire is a validated disease-specific patient-reported outcome...
10.
Anand V, Kane G, Lee A, Scott C, Pislaru S, McCully R, et al.
J Am Soc Echocardiogr . 2022 Jul; 35(11):1139-1145.e3. PMID: 35863546
Background: Cardiac power reflects cardiac performance in terms of energy transferred by the left ventricle to the aorta per unit time. Peak stress cardiac power has been shown to predict...